These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 14609245)
1. Atypical antipsychotics in first admission schizophrenia: medication continuation and outcomes. Mojtabai R; Lavelle J; Gibson PJ; Bromet EJ Schizophr Bull; 2003; 29(3):519-30. PubMed ID: 14609245 [TBL] [Abstract][Full Text] [Related]
2. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026 [TBL] [Abstract][Full Text] [Related]
3. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge. Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223 [TBL] [Abstract][Full Text] [Related]
5. The effects of atypical antipsychotic medications on psychosocial outcomes. Corrigan PW; Reinke RR; Landsberger SA; Charate A; Toombs GA Schizophr Res; 2003 Sep; 63(1-2):97-101. PubMed ID: 12892863 [TBL] [Abstract][Full Text] [Related]
6. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals. Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449 [TBL] [Abstract][Full Text] [Related]
7. [Quality of life of patient with schizophrenia treated by conventional and atypical neuroleptics]. Zaghdoudi L; Homri W; Belaid S; Ben Bechir M; Labbane R Tunis Med; 2009 Sep; 87(9):593-8. PubMed ID: 20180380 [TBL] [Abstract][Full Text] [Related]
8. Effects of antipsychotic medication on psychiatric service utilization and cost. Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980 [TBL] [Abstract][Full Text] [Related]
9. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Menzin J; Boulanger L; Friedman M; Mackell J; Lloyd JR Psychiatr Serv; 2003 May; 54(5):719-23. PubMed ID: 12719504 [TBL] [Abstract][Full Text] [Related]
10. Insight into illness and attitudes toward medications among inpatients with schizophrenia. Sajatovic M; Rosch DS; Sivec HJ; Sultana D; Smith DA; Alamir S; Buckley P; Bingham CR Psychiatr Serv; 2002 Oct; 53(10):1319-21. PubMed ID: 12364685 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of atypical versus typical antipsychotic medication on earnings of schizophrenia patients : estimates from a prospective naturalistic study. Salkever D; Slade E; Karakus M Pharmacoeconomics; 2006; 24(2):123-39. PubMed ID: 16460134 [TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. Swanson JW; Swartz MS; Elbogen EB Schizophr Bull; 2004; 30(1):3-20. PubMed ID: 15176758 [TBL] [Abstract][Full Text] [Related]
14. Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics. Scheller-Gilkey G; Woolwine BJ; Cooper I; Gay O; Moynes KA; Miller AH Am J Drug Alcohol Abuse; 2003 Aug; 29(3):553-66. PubMed ID: 14510040 [TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of atypicals in the UK. Heeg B; Buskens E; Botteman M; Caleo S; Ingham M; Damen J; de Charro F; van Hout B Value Health; 2008 Dec; 11(7):1007-21. PubMed ID: 18489517 [TBL] [Abstract][Full Text] [Related]
16. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study. Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216 [TBL] [Abstract][Full Text] [Related]